semaglutide 0.25 mg or 0.5 mg Medications best known for helping people lose weight and manage diabetes may also be associated with significantly lower rates of substance use disorders, according to new research from UTEP. The study, published Diabetes Medicine - OSEPTIN 0.25

Given the increasing interest in the GLP-1 target, we downloaded clinical trial data for ~3,800 GLP-1 related studies through July 2024 and asked, what other conditions are GLP-1 modulating drugs being tested for

They say it helps people determine what to eat, influences food taste, and affects socialization

Eur Heart J 36:2288-2296

Although studies demonstrate the benefits of long-term medication use to maintain weight loss, dropout rates are high

However, it requires consistent sessions and proper aftercare

Janelle (29:14): Well, and we make that part of it individual too, because we've had, in the very, very beginning, we were so high touch and wanting to talk to them all the time, see how they were doing before we gave them their next round of medications